Skip to main content

and
  1. Article

    Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

    A Correction to this paper has been published: https://doi.org/10.1038/s41591-021-01251-7.

    Simon Dujardin, Caitlin Commins, Aurelien Lathuiliere, Pieter Beerepoot in Nature Medicine (2021)

  2. No Access

    Article

    Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

    Alzheimer’s disease (AD) causes unrelenting, progressive cognitive impairments, but its course is heterogeneous, with a broad range of rates of cognitive decline1. The spread of tau aggregates (neurofibrillary ta...

    Simon Dujardin, Caitlin Commins, Aurelien Lathuiliere, Pieter Beerepoot in Nature Medicine (2020)

  3. No Access

    Article

    Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

    The past decade has witnessed hundreds of reports declaring or refuting genetic association with putative Alzheimer disease susceptibility genes. This wealth of information has become increasingly difficult to...

    Lars Bertram, Matthew B McQueen, Kristina Mullin, Deborah Blacker in Nature Genetics (2007)